Tchaikapharma High Quality Medicines AD (BUL: THQM)
Bulgaria
· Delayed Price · Currency is BGN 17.50
-0.10 (-0.57%)
At close: Nov 19, 2024
THQM Income Statement
Financials in millions BGN. Fiscal year is January - December.
Millions BGN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 49.85 | 48.51 | 43.15 | 42.43 | 40.11 | 34.44 | Upgrade
|
| Other Revenue | - | - | - | - | - | 0.28 | Upgrade
|
| Revenue | 49.85 | 48.51 | 43.15 | 42.43 | 40.11 | 34.72 | Upgrade
|
| Revenue Growth (YoY) | 0.40% | 12.44% | 1.69% | 5.80% | 15.50% | -8.76% | Upgrade
|
| Cost of Revenue | -0.23 | 13.27 | 12.81 | 30.77 | 30.01 | 23.09 | Upgrade
|
| Gross Profit | 50.08 | 35.25 | 30.34 | 11.67 | 10.1 | 11.64 | Upgrade
|
| Selling, General & Admin | 43.13 | 27.6 | 23.99 | 5.68 | 4.96 | 4.37 | Upgrade
|
| Other Operating Expenses | 0.37 | 0.83 | -0.27 | 0.65 | 0.32 | 0.8 | Upgrade
|
| Operating Expenses | 45.98 | 31.24 | 27.29 | 10.21 | 9.51 | 8.69 | Upgrade
|
| Operating Income | 4.09 | 4.01 | 3.05 | 1.46 | 0.59 | 2.95 | Upgrade
|
| Interest Expense | -0.6 | -0.55 | -0.28 | -0.27 | -0.24 | -0.22 | Upgrade
|
| Interest & Investment Income | 0.46 | 0.46 | 0.47 | 0.46 | 0.45 | 0.34 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.03 | -0.01 | -0.07 | -0.06 | -0.03 | -0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.05 | -0.04 | -0.04 | -0.02 | -0.15 | -0.06 | Upgrade
|
| EBT Excluding Unusual Items | 3.88 | 3.87 | 3.13 | 1.56 | 0.62 | 2.97 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | -0 | Upgrade
|
| Pretax Income | 3.88 | 3.87 | 3.13 | 1.56 | 0.62 | 2.96 | Upgrade
|
| Income Tax Expense | 0.54 | 0.47 | 0.34 | 0.17 | 0.2 | 0.4 | Upgrade
|
| Net Income | 3.34 | 3.4 | 2.79 | 1.4 | 0.43 | 2.57 | Upgrade
|
| Net Income to Common | 3.34 | 3.4 | 2.79 | 1.4 | 0.43 | 2.57 | Upgrade
|
| Net Income Growth | -17.90% | 21.79% | 99.86% | 226.17% | -83.33% | -77.07% | Upgrade
|
| Shares Outstanding (Basic) | 94 | 89 | 89 | 89 | 64 | 85 | Upgrade
|
| Shares Outstanding (Diluted) | 94 | 89 | 89 | 89 | 64 | 85 | Upgrade
|
| Shares Change (YoY) | 10.17% | - | - | 39.01% | -25.02% | 1.50% | Upgrade
|
| EPS (Basic) | 0.04 | 0.04 | 0.03 | 0.02 | 0.01 | 0.03 | Upgrade
|
| EPS (Diluted) | 0.04 | 0.04 | 0.03 | 0.02 | 0.01 | 0.03 | Upgrade
|
| EPS Growth | -25.48% | 21.79% | 99.86% | 134.63% | -77.77% | -77.41% | Upgrade
|
| Free Cash Flow | 1.17 | 0.95 | 0.88 | 0.45 | 0.58 | 1.05 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Gross Margin | 100.45% | 72.65% | 70.31% | 27.49% | 25.18% | 33.52% | Upgrade
|
| Operating Margin | 8.21% | 8.26% | 7.06% | 3.43% | 1.47% | 8.49% | Upgrade
|
| Profit Margin | 6.70% | 7.00% | 6.47% | 3.29% | 1.07% | 7.40% | Upgrade
|
| Free Cash Flow Margin | 2.34% | 1.96% | 2.04% | 1.06% | 1.44% | 3.04% | Upgrade
|
| EBITDA | 5.93 | 6.18 | 6.38 | 5.3 | 4.82 | 6.27 | Upgrade
|
| EBITDA Margin | 11.90% | 12.74% | 14.78% | 12.50% | 12.02% | 18.04% | Upgrade
|
| D&A For EBITDA | 1.84 | 2.18 | 3.33 | 3.85 | 4.23 | 3.32 | Upgrade
|
| EBIT | 4.09 | 4.01 | 3.05 | 1.46 | 0.59 | 2.95 | Upgrade
|
| EBIT Margin | 8.21% | 8.26% | 7.06% | 3.43% | 1.47% | 8.49% | Upgrade
|
| Effective Tax Rate | 13.92% | 12.15% | 10.92% | 10.74% | 31.41% | 13.33% | Upgrade
|
| Revenue as Reported | 1.46 | - | - | 42.56 | 40.39 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.